Table 2.

Similarities in HCMV and MCMV

FeatureHCMVMCMV
Prevalence Worldwide seroprevalence: 45% to 100%50  Seroprevalence: 61.7%, 79.4%, and 90%118-120  
Multiple viral strains Diverse viral isolates identified121,122 Diverse viral isolates identified120,123 
Life cycle Primary, chronic, and latent infection Primary, chronic, and latent infection 
Organ disease Characteristic sites: lung, liver, and GI tract Characteristic sites: lung, liver, and GI tract 
Unique immune responses NK-cell memory: NKG2C+ NK cells64,65 NK-cell memory: Ly49H+ NK cells62,63 
 CD8+ T-cell memory inflation124-126  CD8+ T-cell memory inflation126,127 
Resistance to antiviral drugs Mutations in HCMV DNA polymerase and UL97128-130  Mutations in MCMV DNA polymerase and M97130  
FeatureHCMVMCMV
Prevalence Worldwide seroprevalence: 45% to 100%50  Seroprevalence: 61.7%, 79.4%, and 90%118-120  
Multiple viral strains Diverse viral isolates identified121,122 Diverse viral isolates identified120,123 
Life cycle Primary, chronic, and latent infection Primary, chronic, and latent infection 
Organ disease Characteristic sites: lung, liver, and GI tract Characteristic sites: lung, liver, and GI tract 
Unique immune responses NK-cell memory: NKG2C+ NK cells64,65 NK-cell memory: Ly49H+ NK cells62,63 
 CD8+ T-cell memory inflation124-126  CD8+ T-cell memory inflation126,127 
Resistance to antiviral drugs Mutations in HCMV DNA polymerase and UL97128-130  Mutations in MCMV DNA polymerase and M97130  

GI, gastrointestinal.

or Create an Account

Close Modal
Close Modal